ArticleCancers2021

The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models.

Lisa Gherardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.